In shortit helps you eat less, feel fuller longer, and avoid sharp spikes in blood sugar levels
Based on Phase 2 clinical trial data, most participants lost between 3% and 5% of their body weight during the first four weeks
When analyzed by individual agents, liraglutide demonstrated the strongest protective association (OR = 0.13, 95% CI: 0.050.32, p = 0.0001), followed by dulaglutide (OR = 0.26, 95% CI: 0.11-0.60, p = 0.01) and semaglutide (OR = 0.27, 95% CI: 0.080.98, p = 0.046), all of which were statistically significant
This article examines the current understanding of whether GLP-1 agonists help with binge eating, their mechanisms, safety considerations, and alternative evidence-based treatments available through the NHS
Calibrate patients with dedicated coaching relationships demonstrate more consistent adherence to lifestyle modifications
For inclusion, adults ( 18 years old) in the database required a diagnosis code for T2D